Submission Details
| 510(k) Number | K882368 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 08, 1988 |
| Decision Date | August 08, 1988 |
| Days to Decision | 61 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
K882368 is an FDA 510(k) clearance for the REP HDL ELECTROPHORESIS METHOD, a Electrophoresis, Cholesterol Via Esterase-oxidase, Hdl (Class I — General Controls, product code LBT), submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on August 8, 1988, 61 days after receiving the submission on June 8, 1988. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1475.
| 510(k) Number | K882368 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 08, 1988 |
| Decision Date | August 08, 1988 |
| Days to Decision | 61 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
| Product Code | LBT — Electrophoresis, Cholesterol Via Esterase-oxidase, Hdl |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1475 |